middle.news
Polynovo Accelerates Global Growth with 28.9% Sales Surge in FY25
10:46pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
Polynovo Accelerates Global Growth with 28.9% Sales Surge in FY25
10:46pm on Friday 29th of August, 2025 AEST
Key Points
FY25 total revenue up 23.3% to A$129.2 million
Commercial sales growth of 28.9%, led by US and Rest of World markets
FDA PMA submission strategy confirmed post BARDA pivotal trial
Expansion into new international markets with strong regional sales
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Polynovo (ASX:PNV)
OPEN ARTICLE